Nice comeback run for IBM. That being said, an upper target has appeared and it's one we should take seriously. IF long THEN think of taking some profit or tightening the stop as this level approaches. Don't short until we have a '...
While most of the heavyweights have already reported their quarterly earnings, there are still plenty of names left on the docket. And as always, earnings reports can be a powerful catalyst.
Today's trade is in a $39B leading provider of software solutions for the global life sciences sector that is on the verge of breaking multi-year highs with an eye towards making a run at all-time highs.
I just returned from the annual ISPOR show which showcases companies which tell the 'value' of a therapy coming to market ... thru a combination of "evidence synthesis, economic modeling or RWE (Real World Evidence) studies very smart people are able...
Like the rest of the All Star Charts team, I spent last week in New Orleans. It was hot. It was muggy. But the food—oh man, the food—made it all worth it.
I think I hit all the cornerstones of New Orleans cuisine:
